Innovotech Announces Private Placement

Innovotech Inc. (TSX VENTURE:IOT) is pleased to announce that, subject to
regulatory approval, it intends to complete an offering of up to 2,343,750 units
("Units") at a price of $0.32 per Unit for gross proceeds of up to $750,000 by
way of a private placement (the "Offering"). Each Unit is comprised of one (1)
common share ("Common Share") and one (1) Common Share purchase warrant
("Warrant"). Each Warrant entitles the holder to purchase one (1) additional
Common Share at a price of $0.40 per Common Share for a period of three (3)
years following the date of closing.


Innovotech intends to use the proceeds from the Offering to support marketing of
its veterinary and human test kits and to support efforts to gain regulatory
approval of its agricultural industry products.


About Innovotech Inc.:

Innovotech Inc. is a pioneer in the field of biofilm product development,
focused on providing innovative and practical solutions to medical, agricultural
and industrial problems caused by microbial biofilms. Biofilms are organized
communities of microorganisms that exist in virtually every natural environment
and are responsible for a host of diseases in human health, animal health and
agriculture. There are few products or regulatory standards, aside from those of
Innovotech, designed specifically for biofilm-forming organisms.


Innovotech has a broad range of products that address the issue of biofilms
within a number of different industries, including commercially available
products in three market segments; the MBEC Assay(TM), bioFILM PA(TM),
InnovoSCEPT-Human and InnovoSCEPT-Veterinary tests. The MBEC Assay(TM) is a high
throughput biofilm growth device that was recently approved as an ASTM
International standard. bioFILM PA(TM) and InnovoSCEPT-Human are the first
diagnostic tests to assist physicians in the selection of the most effective
antibiotic treatment for patients with biofilm-based chronic infections, while
the InnovoSCEPT veterinary tests are designed to determine the most effective
antibiotic treatment for infections in both large and small animals. 


Innovotech also has three products in advanced stages of development; Agress(R)
is a unique, environmentally friendly seed treatment and plant spray designed to
protect crops against both bacterial and fungal infections, AgreGuard(TM) is a
unique antimicrobial for coating medical devices such as catheters, and
Sani-Lux(TM) is a light-activated, natural hard surface sanitizer.


Connect with us:

Website: www.innovotech.ca

Blog: www.cf-test.ca

Twitter: www.twitter.com/innovotech

Facebook: www.facebook.com/innovotech

Innovotech (TSXV:IOT)
과거 데이터 주식 차트
부터 5월(5) 2024 으로 6월(6) 2024